The Supreme Court has decided to maintain broad access to the abortion pill mifepristone, allowing it to be obtained without an in-person doctor visit. This decision temporarily halts a lower court’s order that would have limited the drug’s availability. The case is part of ongoing litigation concerning the FDA’s safety regulations for mifepristone. This ruling is significant as it impacts access to abortion services and the ongoing legal battles surrounding reproductive rights.
QUESTION: How might the Supreme Court’s decision on mifepristone influence future discussions and policies about reproductive health and rights?
Supreme Court preserves broad access to abortion drug mifepristone
